PYXS · Forms 3, 4, 5
Insider trades at Pyxis Oncology, Inc.
1 insider bought $0 of Pyxis Oncology, Inc. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for Pyxis Oncology, Inc. (PYXS) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| GordonMD Global Investments LP | 10% owner | Buy | 5,517,000 | Form 4 | |||
| Thomas Civik | CEO & Chairman of the Board | Options or other derivatives | Form 4 | ||||
| Jakob Dupont | Director | Options or other derivatives | Form 4 | ||||
| Thomas Civik | Interim CEO | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.